Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Understanding Vape Counter-Marketing Study

9 de novembro de 2026 atualizado por: Shivani Gaiha, Boston Children's Hospital

Countering E-Cigarette Marketing in the Retail Environment Among Adolescents and Young Adults

The goal of this interventional study is to test whether short videos of electronic-cigarette (e-cigarette) counter-marketing lessons work to decrease people's intent to use and smoke e-cigarettes. Using short videos, the investigators hope to inform participants about the marketing strategies that e-cigarette companies use to try to get people to purchase and use e-cigarettes. The investigators hope to find that, after watching the short videos, people will be able to point out when e-cigarette companies are trying to sell their products, and hopefully they will have a lower interest in buying and using e-cigarettes. The investigators also hope participants will learn more about the addictiveness and harmfulness of using e-cigarettes by watching the short videos.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

2556

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

13 anos a 21 anos (Filho, Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • 13-21 years old
  • Fluent in English
  • Owns a smartphone or other device that can be used to complete study activities (e.g., watching videos, responding to electronic surveys)
  • Meets sampling ratio to match the US Census for sex assigned at birth, race, and ethnicity

Exclusion Criteria:

  • Fails survey validation checks (e.g., completing the survey too quickly, providing the same answer to every question)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: New Intervention Group

Participants in this arm will receive a novel intervention developed by the study team.

Participants will view 4 short-form videos filmed by influencers. Influencers convey messaging designed to counter e-cigarette marketing in retail stores.

Comparador Ativo: Pre-existing Intervention

Participants will receive a comparable, pre-existing intervention not developed by the study team.

Participants will view 1 video in the public domain with messaging on e-cigarette marketing tactics.

Outro: Control Condition

Participants will receive a control condition that was not developed by the study team.

Participants will view 4 short-form influencer-generated videos on topics that are unrelated to counter e-cigarette marketing in retail stores.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Susceptibility to use e-cigarettes among those who never used
Prazo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).

Susceptibility to use e-cigarettes among those who never used [Susceptibility scores are calculated based on the following 4 items:

  1. Do you think you will try/ use a nicotine vape in the next year?
  2. Do you think that you will try/use a nicotine vape soon?
  3. If one of your best friends were to offer you a nicotine vape, would you try/use it?
  4. Have you ever been curious about trying/using a nicotine vape? Response options for the first three items are: 1 = definitely not, 2 = probably not, 3 = probably yes, and 4 = definitely yes, and for the fourth item were: 1 = not at all curious, 2 = a little curious, 3 = somewhat curious, and 4 = very curious. Per Persoskie and O'Brien (2022), the four items are averaged to create a single index.]

O'Brien EK, Baig SA, Persoskie A. Developing and Validating Measures of Absolute and Relative E-Cigarette Product Risk Perceptions: Single Items Can Be Surprisingly Comprehensive. Nicotine Tob Res. 2022;24(3):316-323. doi:10.1093/ntr/n

From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
E-cigarette Use
Prazo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
  1. Have you EVER used any of the following products, even one or two puffs

  2. During the PAST 30 DAYS, have you used any of the following products, even one or two puffs?

  3. During the PAST 30 DAYS, on how many days (from 0 days to 30 days) did you use a… (numeric response)

  4. During the PAST 7 DAYS, have you used any of the following products, even one or two puffs?

  5. During the PAST 7 DAYS, on how many days (from 0 days to 7 days) did you use a…

  6. Other questions on age at first use, friend use and family use. All questions relate to the following products:

    • Nicotine vape
    • Some kind of vape (Don't know what was in it)
    • Cigarette
    • Nicotine pouch
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
Intent to use e-cigarettes and cigarettes
Prazo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

Do participants plan to use e-cigarettes and cigarettes?

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Vaping attitudes and norms
Prazo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

We will measure people's attitudes and acceptance towards vaping using: Vaping Attitudes Scale (5-point Likert-type; high score: positive attitude) and Mean Vaping Injunctive Norms Scale (3-item)

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Pro-vaping marketing exposure (focused on retail), including marketing receptivity
Prazo: From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)

Can people understand and recognize e-cigarette marketing? Does it have an effect on them?

From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
Marketing exposure on social media
Prazo: Day 1 (Baseline/Pre-intervention)

Questions to assess social media use, frequency, and platforms.

Day 1 (Baseline/Pre-intervention)
Anti-vaping content exposure
Prazo: Day 1 (Baseline/Pre-intervention)

Prior exposure to having seen content that dissuades people from using vapes and locations where they saw it.

Day 1 (Baseline/Pre-intervention)
Knowledge of e-cigarette retail marketing
Prazo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

How much do people know about e-cigarette retail marketing (based on key messages and facts shown in video content)?

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Perceived message effectiveness
Prazo: Day 1 (Immediately post-intervention)

We will test the effectiveness of the videos using two scales, the Message Assessment Scale for Tobacco Prevention Campaigns, and the Perceived Message Effectiveness Scale (6-item).

Day 1 (Immediately post-intervention)
Video acceptability
Prazo: Day 1 (Immediately post-treatment)

We will test how much people enjoyed and connected with the videos based on a quality rating scale and a question on alternative ways to receive content.

Day 1 (Immediately post-treatment)

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Recruitment, enrollment, and attrition
Prazo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

We want to measure recruitment and enrollment success, and how many people complete the study.

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Video feasibility
Prazo: Day 1 (Immediately post-intervention)

We want to test whether people were able to watch the videos, how many of them they watched and for how long, and what devices they used to watch them.

Day 1 (Immediately post-intervention)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

15 de novembro de 2026

Conclusão Primária (Estimado)

30 de abril de 2027

Conclusão do estudo (Estimado)

30 de abril de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

3 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

9 de novembro de 2026

Primeira postagem (Real)

13 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

13 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

9 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever